|
logo
|
search close english website menuclose
  • 商务咨询

    联系人:黄先生

    电话:028-87771674

    邮箱:huangbo@sintanovo.com

在线留言×
guanbi
iCVETide®计算化学平台涵盖内容包括虚拟筛选,骨架跃迁,ADMET,氨基酸库等等

诺和晟泰自主研发的iCVETide®计算化学平台,是我们攻坚多肽新药的核心引擎与创新壁垒。平台深度融合计算化学(CADD)与人工智能(AIDD),完整覆盖从靶点早期验证、智能虚拟筛选、先导化合物优化到临床前研究的全流程。

iCVETide®是我们实现多肽药物跨越式研发的“加速器”与“决策中心”。 它驱动着我们同步推进两类战略:一方面,以前沿的AI模拟与设计能力,攻克全新靶点,挑战全球首创(First-in-Class);另一方面,对热门靶点进行极致优化,高效产出具有“同类最优”(Best-in-Class)潜力的候选分子。这一平台能力确保我们能快速布局并推进具备快速上市(First-to-Market)前景的IND项目,系统性突破多肽药物研发的效率瓶颈。

简而言之,iCVETide®代表了我们将计算智能转化为差异化管线优势的核心能力。

CADD: Precision Peptide Modeling
Virtual Screening
虚拟筛选

利用小分子化合物与药物靶标间的分子对接运算,快速地从小分子数据库中遒选出具有成药性的活性化合物

Using molecular docking between small molecules and drug targets, select bioactive compounds with drug-like properties from small molecule databases.
Scaffold Hopping
骨架跃迁

以已知的活性化合物为起点,通过改变分子的核心结构获得新颖的化学结构

Starting from known active compounds, new chemical structures are obtained bymodifying the core structure of the molecule.
(MD & Gaussian-Accelerated Computing)
MD&高斯加速

全原子模拟,分子动力学模拟体系,高斯加速动力学GaMD,多肽高性能计算,动力学轨迹淡影,高性能计算

By solving Newton's equations of motion, the trajectories of molecules, atoms,or ions in specific times and spaces are simulated.
Thermodynamic integral
热力学积分

以已知的活性化合物为起点,通过改变分子的核心结构获得新颖的化学结构

Starting from known active compounds, new chemical structures are obtained bymodifying the core structure of the molecule.
ADMET
ADMET

药代动力学“吸收、分布、代谢、排泄、毒性”五大维度,多肽ADMET预测,ADMET 性质模拟,计算多肽药代动力学

Five dimensions of pharmacokinetics: absorption, distribution, metabolism, excretion, and toxicity. Peptide ADMET prediction, ADMET property simulation, and calculation of peptide pharmacokinetics
3D-QSAR
三维定量构效关系

Predicting the activity of new compounds by analyzing the quantitative relationship between the three-dimensional structural features of compounds and their biological activity.
Amino acid library
超大氨基酸集成数据库

我们自主构建的超大规模氨基酸虚拟库,能快速锁定潜力候选分子,并结合AI生成与骨架拼接技术,高效创制结构新颖的多肽分子,大幅拓展可成药化学空间。

We have independently constructed an ultra-large virtual amino acid library, which enables rapid identification of promising candidate molecules. By integrating AI-driven generation and scaffold-hopping technologies, we efficiently create novel peptide structures, significantly expanding the accessible chemical space for drug discovery.
成果发表
《成都诺和企业文化践行者》—践行文化,榜样力量第Ⅵ期
2026-03-25
  • 商务咨询

    联系人:黄先生

    电话:028-87771674

    邮箱:huangbo@sintanovo.com

在线留言×
guanbi